Every SEC Form 3/4/5 on record for this filer (CIK 1743658) — 1 issuer, 8 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | Director | 2018-06-20 → 2026-06-05 | 14 | −$421,246 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XERS | 2026-06-04 | Sell | 20,000 | $6.09 | $121,800 | 95,000 |
| XERS | 2025-08-12 | Sell | 42,500 | $7.28 | $309,400 | 115,000 |
| XERS | 2023-11-20 | Buy | 5,410 | $1.84 | $9,954 | 5,410 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.